Literature DB >> 22076471

Molecular dynamics of Mycobacterium tuberculosis KasA: implications for inhibitor and substrate binding and consequences for drug design.

Benjamin Schaefer1, Caroline Kisker, Christoph A Sotriffer.   

Abstract

Inhibition of the production of fatty acids as essential components of the mycobacterial cell wall has been an established way of fighting tuberculosis for decades. However, increasing resistances and an outdated medical treatment call for the validation of new targets involved in this crucial pathway. In this regard, the β-ketoacyl ACP synthase KasA is a promising enzyme. In this study, three molecular dynamics simulations based on the wildtype crystal structures of inhibitor bound and unbound KasA were performed in order to investigate the flexibility and conformational space of this target. We present an exhaustive analysis of the binding-site flexibility and representative pocket conformations that may serve as new starting points for structure-based drug design. We also revealed a mechanism which may account for the comparatively low binding affinity of thiolactomycin. Furthermore, we examined the behavior of water molecules within the binding pocket and provide recommendations how to handle them in the drug design process. Finally, we analyzed the dynamics of a channel that accommodates the long-chain fatty acid substrates and, thereby, propose a mechanism of substrate access to this channel and how products are most likely released.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22076471     DOI: 10.1007/s10822-011-9483-4

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  24 in total

1.  Development and testing of a general amber force field.

Authors:  Junmei Wang; Romain M Wolf; James W Caldwell; Peter A Kollman; David A Case
Journal:  J Comput Chem       Date:  2004-07-15       Impact factor: 3.376

2.  Automatic atom type and bond type perception in molecular mechanical calculations.

Authors:  Junmei Wang; Wei Wang; Peter A Kollman; David A Case
Journal:  J Mol Graph Model       Date:  2006-02-03       Impact factor: 2.518

3.  The solution structure of acyl carrier protein from Mycobacterium tuberculosis.

Authors:  Hing C Wong; Gaohua Liu; Yong-Mei Zhang; Charles O Rock; Jie Zheng
Journal:  J Biol Chem       Date:  2002-02-01       Impact factor: 5.157

4.  Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis.

Authors:  L Kremer; J D Douglas; A R Baulard; C Morehouse; M R Guy; D Alland; L G Dover; J H Lakey; W R Jacobs; P J Brennan; D E Minnikin; G S Besra
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

5.  Inhibition of beta-ketoacyl-acyl carrier protein synthases by thiolactomycin and cerulenin. Structure and mechanism.

Authors:  A C Price; K H Choi; R J Heath; Z Li; S W White; C O Rock
Journal:  J Biol Chem       Date:  2000-10-24       Impact factor: 5.157

6.  Crystal structure of the Mycobacterium tuberculosis enoyl-ACP reductase, InhA, in complex with NAD+ and a C16 fatty acyl substrate.

Authors:  D A Rozwarski; C Vilchèze; M Sugantino; R Bittman; J C Sacchettini
Journal:  J Biol Chem       Date:  1999-05-28       Impact factor: 5.157

7.  Platensimycin is a selective FabF inhibitor with potent antibiotic properties.

Authors:  Jun Wang; Stephen M Soisson; Katherine Young; Wesley Shoop; Srinivas Kodali; Andrew Galgoci; Ronald Painter; Gopalakrishnan Parthasarathy; Yui S Tang; Richard Cummings; Sookhee Ha; Karen Dorso; Mary Motyl; Hiranthi Jayasuriya; John Ondeyka; Kithsiri Herath; Chaowei Zhang; Lorraine Hernandez; John Allocco; Angela Basilio; José R Tormo; Olga Genilloud; Francisca Vicente; Fernando Pelaez; Lawrence Colwell; Sang Ho Lee; Bruce Michael; Thomas Felcetto; Charles Gill; Lynn L Silver; Jeffery D Hermes; Ken Bartizal; John Barrett; Dennis Schmatz; Joseph W Becker; Doris Cully; Sheo B Singh
Journal:  Nature       Date:  2006-05-18       Impact factor: 49.962

8.  Purification and biochemical characterization of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthases KasA and KasB.

Authors:  M L Schaeffer; G Agnihotri; C Volker; H Kallender; P J Brennan; J T Lonsdale
Journal:  J Biol Chem       Date:  2001-10-12       Impact factor: 5.157

9.  Slow onset inhibition of bacterial beta-ketoacyl-acyl carrier protein synthases by thiolactomycin.

Authors:  Carl A Machutta; Gopal R Bommineni; Sylvia R Luckner; Kanishk Kapilashrami; Bela Ruzsicska; Carlos Simmerling; Caroline Kisker; Peter J Tonge
Journal:  J Biol Chem       Date:  2009-12-16       Impact factor: 5.157

Review 10.  The mechanism of isoniazid killing: clarity through the scope of genetics.

Authors:  Catherine Vilchèze; William R Jacobs
Journal:  Annu Rev Microbiol       Date:  2007       Impact factor: 15.500

View more
  3 in total

1.  Conformational flexibility of DENV NS2B/NS3pro: from the inhibitor effect to the serotype influence.

Authors:  Erika Piccirillo; Benjamin Merget; Christoph A Sotriffer; Antonia T do Amaral
Journal:  J Comput Aided Mol Des       Date:  2016-02-29       Impact factor: 3.686

2.  Structural basis for the recognition of mycolic acid precursors by KasA, a condensing enzyme and drug target from Mycobacterium tuberculosis.

Authors:  Johannes Schiebel; Kanishk Kapilashrami; Agnes Fekete; Gopal R Bommineni; Christin M Schaefer; Martin J Mueller; Peter J Tonge; Caroline Kisker
Journal:  J Biol Chem       Date:  2013-10-09       Impact factor: 5.157

3.  Design, Synthesis and Biological Evaluation of Some Triazole Schiff's Base Derivatives as Potential Antitubercular Agents.

Authors:  Asma A Sager; Zainab S Abood; Wedad M El-Amary; Salah M Bensaber; Inass A Al-Sadawe; Nouri B Ermeli; Salah B Mohamed; Mohamed Al-Forgany; Ibrahim A Mrema; Mabrouk Erhuma; Anton Hermann; Abdul M Gbaj
Journal:  Open Med Chem J       Date:  2018-04-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.